These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP. Diaz-Sylvester PL, Porta M, Copello JA. Am J Physiol Cell Physiol; 2008 Apr; 294(4):C1103-12. PubMed ID: 18305228 [Abstract] [Full Text] [Related]
3. A retrograde signal from RyR1 alters DHP receptor inactivation and limits window Ca2+ release in muscle fibers of Y522S RyR1 knock-in mice. Andronache Z, Hamilton SL, Dirksen RT, Melzer W. Proc Natl Acad Sci U S A; 2009 Mar 17; 106(11):4531-6. PubMed ID: 19246389 [Abstract] [Full Text] [Related]
4. Phenotyping malignant hyperthermia susceptibility by measuring halothane-induced changes in myoplasmic calcium concentration in cultured human skeletal muscle cells. Girard T, Treves S, Censier K, Mueller CR, Zorzato F, Urwyler A. Br J Anaesth; 2002 Oct 17; 89(4):571-9. PubMed ID: 12393358 [Abstract] [Full Text] [Related]
5. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia. Duke AM, Hopkins PM, Halsall PJ, Steele DS. Br J Anaesth; 2006 Sep 17; 97(3):320-8. PubMed ID: 16849381 [Abstract] [Full Text] [Related]
7. Malignant hyperthermia, environmental heat stress, and intracellular calcium dysregulation in a mouse model expressing the p.G2435R variant of RYR1. Lopez JR, Kaura V, Diggle CP, Hopkins PM, Allen PD. Br J Anaesth; 2018 Oct 17; 121(4):953-961. PubMed ID: 30236258 [Abstract] [Full Text] [Related]
8. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia. Duke AM, Hopkins PM, Halsal JP, Steele DS. Anesthesiology; 2004 Dec 17; 101(6):1339-46. PubMed ID: 15564941 [Abstract] [Full Text] [Related]
9. Novel ryanodine receptor mutation that may cause malignant hyperthermia. Kaufmann A, Kraft B, Michalek-Sauberer A, Weigl LG. Anesthesiology; 2008 Sep 17; 109(3):457-64. PubMed ID: 18719443 [Abstract] [Full Text] [Related]
10. Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala. Wehner M, Rueffert H, Koenig F, Olthoff D. Genet Test; 2003 Sep 17; 7(3):203-11. PubMed ID: 14641996 [Abstract] [Full Text] [Related]
11. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Yang T, Riehl J, Esteve E, Matthaei KI, Goth S, Allen PD, Pessah IN, Lopez JR. Anesthesiology; 2006 Dec 17; 105(6):1164-75. PubMed ID: 17122579 [Abstract] [Full Text] [Related]
12. Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia. Jiang D, Chen W, Xiao J, Wang R, Kong H, Jones PP, Zhang L, Fruen B, Chen SR. J Biol Chem; 2008 Jul 25; 283(30):20813-20. PubMed ID: 18505726 [Abstract] [Full Text] [Related]
13. Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice. Feng W, Barrientos GC, Cherednichenko G, Yang T, Padilla IT, Truong K, Allen PD, Lopez JR, Pessah IN. Mol Pharmacol; 2011 Mar 25; 79(3):420-31. PubMed ID: 21156754 [Abstract] [Full Text] [Related]
14. Results of contracture tests with halothane, caffeine, and ryanodine depend on different malignant hyperthermia-associated ryanodine receptor gene mutations. Fiege M, Wappler F, Weisshorn R, Ulrich Gerbershagen M, Steinfath M, Schulte Am Esch J. Anesthesiology; 2002 Aug 25; 97(2):345-50. PubMed ID: 12151923 [Abstract] [Full Text] [Related]
15. Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle. Barrientos GC, Feng W, Truong K, Matthaei KI, Yang T, Allen PD, Lopez JR, Pessah IN. J Biol Chem; 2012 Jan 20; 287(4):2863-76. PubMed ID: 22139840 [Abstract] [Full Text] [Related]
16. Increased sensitivity of the ryanodine receptor to halothane-induced oligomerization in malignant hyperthermia-susceptible human skeletal muscle. Glover L, Heffron JJ, Ohlendieck K. J Appl Physiol (1985); 2004 Jan 20; 96(1):11-8. PubMed ID: 12959958 [Abstract] [Full Text] [Related]
17. Novel double and single ryanodine receptor 1 variants in two Austrian malignant hyperthermia families. Kaufmann A, Kraft B, Michalek-Sauberer A, Weindlmayr M, Kress HG, Steinboeck F, Weigl LG. Anesth Analg; 2012 May 20; 114(5):1017-25. PubMed ID: 22415532 [Abstract] [Full Text] [Related]
18. Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. Yuen B, Boncompagni S, Feng W, Yang T, Lopez JR, Matthaei KI, Goth SR, Protasi F, Franzini-Armstrong C, Allen PD, Pessah IN. FASEB J; 2012 Mar 20; 26(3):1311-22. PubMed ID: 22131268 [Abstract] [Full Text] [Related]
19. Functional characterization of malignant hyperthermia-associated RyR1 mutations in exon 44, using the human myotube model. Wehner M, Rueffert H, Koenig F, Olthoff D. Neuromuscul Disord; 2004 Jul 20; 14(7):429-37. PubMed ID: 15210166 [Abstract] [Full Text] [Related]
20. Effects of caffeine, halothane, and 4-chloro-m-cresol on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis. Bina S, Cowan G, Karaian J, Muldoon S, Mongan P, Bünger R. Anesthesiology; 2006 Jan 20; 104(1):90-100. PubMed ID: 16394695 [Abstract] [Full Text] [Related] Page: [Next] [New Search]